Diverse Models for the Prediction of Dual mTOR and PI3K Inhibitory Activities of Substituted 4-morpholinopyrrolopyrimidines

Publisher： Bentham Science Publishers

E-ISSN： 1875-628x|11|4|454-473

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.11, Iss.4, 2014-05, pp. : 454-473

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Activation of PI3K/Akt/mTOR Pathway and Dual Inhibitors of PI3K and mTOR in Endometrial Cancer

By  

Current Medicinal Chemistry, Vol. 21, Iss. 26, 2014-09 ,pp. : 3070-3080

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Hot Topic Potential Value and Limitation of Dual Inhibitors of PI3K and mTOR in the Treatment of Cancer)

By  

Current Cancer Drug Targets, Vol. 13, Iss. 2, 2013-02 ,pp. : 117-120

Bentham Science Publishers

Access to resources Recommend Favorite

Dual Inhibition of PI3-Kinase and mTOR in Renal Cell Carcinoma

By  

Current Cancer Drug Targets, Vol. 13, Iss. 2, 2013-02 ,pp. : 126-142

Bentham Science Publishers

Access to resources Recommend Favorite

Dual Inhibitors of PI3K/mTOR or mTOR-Selective Inhibitors: Which Way Shall We Go?

By  

Current Medicinal Chemistry, Vol. 18, Iss. 36, 2011-12 ,pp. : 5528-5544

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Developments of Small Molecule PI3K/mTOR Dual Inhibitors

By  

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 14, 2013-12 ,pp. : 2047-2059

Bentham Science Publishers

Access to resources Recommend Favorite